FDA Inspection 1150646 — Arizona Center for Reproductive Endocrinology & Infertility
The FDA completed an inspection of Arizona Center for Reproductive Endocrinology & Infertility on August 26, 2021 in Tucson, AZ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 26, 2021
- Fiscal Year
- 2021
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Tucson, AZ (United States)